Preoperative Serum Copeptin Can Predict Delayed Hyponatremia after Pituitary Surgery in the Absence of Arginine Vasopressin Deficiency
Endocrinology and Metabolism · 2024
DOI: 10.3803/enm.2023.1792 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Endocrinology and Metabolism, 2024. Verfasst von Ho Kang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea. Hauptthemen laut MEDLINE: Diabetes Insipidus, Neurogenic, Glycopeptides, Hyponatremia, Pituitary Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korean Endocrinology Society, Seoul National University.
Abstract (Originalsprache)
Background
Delayed postoperative hyponatremia (DPH) is the most common cause of readmission after pituitary surgery. In this study, we aimed to evaluate the cutoff values of serum copeptin and determine the optimal timing for copeptin measurement for the prediction of the occurrence of DPH in patients who undergo endoscopic transsphenoidal approach (eTSA) surgery and tumor resection.
Methods
This was a prospective observational study of 73 patients who underwent eTSA surgery for pituitary or stalk lesions. Copeptin levels were measured before surgery, 1 hour after extubation, and on postoperative days 1, 2, 7, and 90.
Results
Among 73 patients, 23 patients (31.5%) developed DPH. The baseline ratio of copeptin to serum sodium level showed the highest predictive performance (area under the curve [AUROC], 0.699), and its optimal cutoff to maximize Youden’s index was 2.5×10–11, with a sensitivity of 91.3% and negative predictive value of 92.0%. No significant predictors were identified for patients with transient arginine vasopressin (AVP) deficiency. However, for patients without transient AVP deficiency, the copeptin-to-urine osmolarity ratio at baseline demonstrated the highest predictive performance (AUROC, 0.725). An optimal cutoff of 6.5×10–12 maximized Youden’s index, with a sensitivity of 92.9% and a negative predictive value of 94.1%.
Conclusion
The occurrence of DPH can be predicted using baseline copeptin and its ratio with serum sodium or urine osmolarity only in patients without transient AVP deficiency after pituitary surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
- Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
- Department of Laboratory Medicine, Seoul Clinical Laboratories, Yongin, Korea.
- Pituitary Center, Seoul National University Hospital, Seoul, Korea.
- Department of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Förderung
- Korean Endocrinology Society
- Seoul National University
Zitieren
APA
Kang, H., Park, S. S., Kim, Y. H., Lim, H. S., Lee, M. K., Lee, K. R., Kim, J. H., & Kim, Y. H. (2024). Preoperative Serum Copeptin Can Predict Delayed Hyponatremia after Pituitary Surgery in the Absence of Arginine Vasopressin Deficiency. Endocrinology and Metabolism. https://doi.org/10.3803/enm.2023.1792
Vancouver
Kang H, Park SS, Kim YH, Lim HS, Lee MK, Lee KR, et al. Preoperative Serum Copeptin Can Predict Delayed Hyponatremia after Pituitary Surgery in the Absence of Arginine Vasopressin Deficiency. Endocrinology and Metabolism. 2024. doi:10.3803/enm.2023.1792
BibTeX
@article{Kang2024,
author = {Kang, Ho and Park, Seung Shin and Kim, Yoo Hyung and Lim, Hwan Sub and Lee, Mi-Kyeong and Lee, Kyoung-Ryul and Kim, Jung Hee and Kim, Yong Hwy},
title = {Preoperative Serum Copeptin Can Predict Delayed Hyponatremia after Pituitary Surgery in the Absence of Arginine Vasopressin Deficiency},
journal = {Endocrinology and Metabolism},
year = {2024},
doi = {10.3803/enm.2023.1792}
}
EUVIMED